MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1079.85%
Quick Ratio
1079.85%
Debt to Asset Ratio
9.09%
Unit: Dollar
Assets Breakdown
    • Marketable securities
    • Accounts receivable
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Retained earnings
    • Additional paid-in capital
    • Accounts payable and accrued exp...
    • Others
Balance Sheets
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Cash and cash equivalents
1,791,474
5,763,618
3,379,212
3,957,752
Marketable securities
6,680,834
4,796,568
7,475,377
6,767,282
Accounts receivable
2,723,404
2,654,675
2,360,682
2,015,529
Prepaids and other assets
90,560
109,108
171,574
415,093
Total current assets
11,286,272
13,323,969
13,386,845
13,155,656
Property and equipment, net
92,355
103,674
116,059
131,526
Operating lease right-of-use
0
0
29,388
72,747
Other assets
120,771
120,783
120,754
225,649
Total assets
11,499,398
13,548,426
13,653,046
13,585,578
Current operating lease liabilities
0
0
28,834
71,362
Accounts payable and accrued expenses
978,541
869,964
991,169
874,379
Dividend payable to shareholders
-
1,717,627
-
-
Current portion of us tax reform transition tax and income taxes payable
66,628
722,104
718,796
713,153
Total current liabilities
1,045,169
3,309,695
1,738,799
1,658,894
Us tcja transition tax payable
-
-
0
0
Long term operating lease liabilities
-
-
0
0
Total liabilities
1,045,169
3,309,695
1,738,799
1,658,894
Common stock, 0.0001 par value authorized 50,000,000 shares 23,519,672 and 23,519,672 shares issued, and 22,901,692 and 22,905,992 shares outstanding at april 30, 2026 and october 31, 2025, respectively
2,352
2,352
2,352
2,352
Additional paid-in capital
1,696,785
1,688,166
1,679,547
1,675,148
Retained earnings
9,081,808
8,848,822
10,533,589
10,533,691
Accumulated other comprehensive income
254,960
280,358
278,045
285,577
Stockholders' equity before treasury stock
11,035,905
10,819,698
12,493,533
-
Treasury stock, at cost 613,680 and 561,529 common shares held on october 31, 2025 and 2024, respectively
-
-
579,286
-
Treasury stock, at cost 617,980 and 613,680 common shares held at april 30, 2026 and october 31, 2025, respectively
581,676
580,967
-
570,084
Total stockholders' equity
10,454,229
10,238,731
11,914,247
11,926,684
Total liabilities and stockholders' equity
11,499,398
13,548,426
13,653,046
13,585,578
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$6,680,834 Accounts receivable$2,723,404 Cash and cashequivalents$1,791,474 Prepaids and other assets$90,560 Total current assets$11,286,272 Other assets$120,771 Property and equipment,net$92,355 Total assets$11,499,398 Total liabilities andstockholders' equity$11,499,398 Total stockholders'equity$10,454,229 Total liabilities$1,045,169 Treasury stock, at cost617,980 and 613,680...$581,676 Stockholders' equity beforetreasury stock$11,035,905 Total currentliabilities$1,045,169 Retained earnings$9,081,808 Additional paid-in capital$1,696,785 Accumulated othercomprehensive income$254,960 Common stock, 0.0001par value...$2,352 Accounts payable andaccrued expenses$978,541 Current portion of us taxreform transition tax...$66,628

Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv, Inc. (PBSV)